ArticleAmerican journal of preventive cardiology2025

Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease.

Aaron King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.